Hepatic fatty acid profile of rats fed a triheptanoin-based ketogenic diet;Perfil de ácidos grasos de hígados de ratones alimentados con una dieta cetogénica basada en triheptanoína

Nutricion Hospitalaria

Volumn 32, Issue 1, 2015, Pages 265-269

  de Melo, Ingrid Sofia Vieira ^a   Ataide, Terezinha da Rocha ^b   de Oliveira, Suzana Lima ^b   Bueno, Nassib Bezerra ^b   de Freitas, Johnnatan Duarte ^a   Sant'Ana, Antônio Euzébio Goulart ^b  

^a Institutio Federal de Educacao Ciencia Tecnologia Alagoas Brazil   (Brazil)

^b FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

Author keywords

Fatty acid profile; Ketogenic diet; Medium chain triacylglycerols; Trienantin

Indexed keywords

GLYCINE MAX; NICA; RATTUS; RATTUS NORVEGICUS;

FATTY ACID; TRIACYLGLYCEROL; TRIHEPTANOIN;

ANIMAL; DIETARY SUPPLEMENT; KETOGENIC DIET; LIVER; MALE; METABOLISM; METABOLOMICS; PROCEDURES; RAT;

ANIMALS; DIETARY SUPPLEMENTS; FATTY ACIDS; KETOGENIC DIET; LIVER; MALE; METABOLOMICS; RATS; TRIGLYCERIDES;

EID: 84936758360     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2015.32.1.9033     Document Type: Article

References (21)

1. Levy RG, Cooper PN, Giri P. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database. Syst Rev 2012; 3: CD001903.
2. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. A randomized trial of classical and medium- chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009; 50: 1109-1117.
3. Roe CR, Sweetman L, Roe DS, David F, Brunengraber H. Treatment of cardiomyopathy and rhabdomyolysis in longchain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 2002; 110: 259-269.
4. Kim TH, Borges K, Petrou S, Reid CA. Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy. Epilepsy Res 2013; 103: 101-105.
5. Willis S, Stoll J, Sweetman L, Borges K. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol Dis 2010; 40: 565-572.
6. Borges K, Sonnewald U. Triheptanoin - a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment? Epilepsy Res 2012; 100: 239-244.
7. Gama IR, Trindade-Filho EM, Oliveira SL, Bueno NB, Melo IT, Cabral-Junior CR, da Rocha Ataide, T. (2014). Effects of ketogenic diets on the occurrence of pilocarpine-induced status epilepticus of rats. Metabolic brain disease, 1-6.
8. Roe CR, Mochel F. Anaplerotic diet therapy in inherited metabolic disease: Therapeutic potential. J Inherit Metab Dis 2006; 29: 332-340.
9. Mochel F, Delonlay P, Touat G, Brunengraber H, Kinamn RP, Rabier D, et al. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 2005; 84: 305-312.
10. Ataíde TR, Oliveira SL, Da Silva FM, Vitorino Silva LGC, Tavares MCN, Sant'Ana AEG. Toxicological analysis of the chronic consumption of diheptanoin and triheptanoin in rats. Int J Food Sci and Tech 2009; 44: 484-492.
11. Bueno NB, Silva MAF, Melo ISV, Ataíde TR, Oliveira SL, Sant'Ana AEG. Hepatic fatty acid profile of rats with AIN-93 diet-induced steatosis attenuated by the partial substitution of soybean oil by diheptanoin and triheptanoin. Arq Bras Endocrinol Metab 2010; 54: 584-587.
12. Lucena ALM, Oliveira SL, Ataíde TR, Silva AX, Cabral Jr CR, Oliveira MAR, et al. High-fat diet based on trienantin has no adverse metabolic effects in rats. Eur J Lipid Sci Technol 2010; 112: 166-172.
13. Afman, LA, Müller M. Human nutrigenomics of gene regulation by dietary fatty acids. Prog Lipid Res 2012; 51: 63-70.
14. Hulbert AJ, Turner N, Storlien LH, Else PL. Dietary fats and membrane function: implications for metabolism and disease. Biol Rev 2005; 80: 155-169.
15. Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T, et al Crucial role of a long-chain fatty acid elongase Elovl6, in obesity-induced insulin resistance. Nat Med 2007; 13: 1193-1202.
16. Reeves P. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 1997; 127: 838S-841S.
17. Folch JS, Lees M, Stanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957; 226: 497-507.
18. Ntambi JM, Miyazaki M. Regulation of stearoyl-CoA desaturase and role in metabolism. Prog Lipid Res 2004; 43: 91-104.
19. Ntambi JM, Choi Y, Park Y, Peters JM, Pariza MW. Effects of conjugated linoleic acid (CLA) on immune responses, body composition and Stearoyl-CoA Desaturase. Can J Appl Physio 2002; 27: 617-628.
20. Tanaka S, Yagi Y, Yamazaki T, Mitsumoto A, Kobayashi D, Kudo N, Kawashima Y. Characterization of fatty acid profile in the liver of SHR/NDmcr-cp (cp/cp) rats, a model of the metabolic syndrome. Biol Pharm Bull 2012; 35: 184-91.
21. Sampath H, Ntambi JM. The fate and intermediary metabolism of stearic acid. Lipids 2005; 40: 1187-1191.